Source Link
Excerpt:
Is the Defense Department still preparing to fight biological warfare as if it’s 1970?
When preparing for biological warfare, most nations picture scenarios in which an enemy openly sprays traditional agents over wide areas to kill their adversaries. However, revolutionary capabilities in the life sciences and biotechnology have transformed the threat. China’s approach to warfare, combined with these emerging technologies, reveals new vulnerabilities among Western forces that, to date, have not been fully acknowledged. In no small measure, this is due to the U.S. government’s continued reliance on a 20th-century strategy for countering weapons of mass destruction. In particular, as China is a major nuclear power, it cannot be threatened after it uses biological weapons as easily as a non-nuclear state. Given these points, can China be deterred from using such advanced biological weapons during a regional crisis in the Indo-Pacific, especially an invasion of Taiwan? And if not, is it possible to mitigate the damage from such a scenario?
Although Western attention has focused on the rapid expansion of China’s nuclear and conventional warfighting capabilities, one ought to expect equal analysis of China’s biological warfare potential. By examining China’s most recent efforts at biological research, we put forward that it has bypassed 20th-century Western concepts of biological warfare and has new capabilities that could be effective across the entire conflict spectrum. Given China’s new capabilities and nuclear arsenal, we assess that standard strategies of deterrence and protection likely will not work in the future. New approaches and new concepts will be necessary if the United States is to prepare itself for potentially new forms of biological warfare in the 21st century.